{"id":63620,"date":"2025-01-15T00:04:59","date_gmt":"2025-01-15T00:04:59","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/01\/15\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/"},"modified":"2025-01-15T00:04:59","modified_gmt":"2025-01-15T00:04:59","slug":"serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/","title":{"rendered":"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors"},"content":{"rendered":"<div>\n<p align=\"justify\">HUNTSVILLE, AL, Jan.  14, 2025  (GLOBE NEWSWIRE) &#8212; <strong><u>Serina Therapeutics, Inc.<\/u><\/strong> (\u201cSerina\u201d) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform<sup>&#x2122;<\/sup> drug delivery technology, today announced the appointment of Karen J. Wilson to the Board of Directors.<\/p>\n<p align=\"justify\">&#8220;We are excited to welcome Karen to the Board of Directors. Karen\u2019s financial expertise and deep understanding of the biotech landscape will play a crucial role in guiding our strategic initiatives and delivering transformative therapies to patients,\u201d said Steve Ledger, Serina\u2019s Chief Executive Officer.<\/p>\n<p align=\"justify\">Ms. Wilson brings over three decades of leadership experiences in the life sciences sector. She currently serves as a board director for Connect Biopharma Holdings Limited, Elicio Therapeutics, Inc. and LAVA Therapeutics N.V. Previously, she held the position of Senior Vice President of Finance at Jazz Pharmaceuticals plc, where she also served as Principal Accounting Officer and Vice President of Finance. Prior to joining the Jazz Pharmaceuticals organization in February 2011, she held senior finance roles at PDL BioPharma, ViroLogic, and Novare Surgical Systems and was a consultant and auditor for Deloitte &amp; Touche LLP. Ms. Wilson is a Certified Public Accountant and received a B.S. in Business from the University of California, Berkeley.<\/p>\n<p align=\"justify\">Ms. Wilson stated, &#8220;I am excited to join Serina at such a pivotal time in its growth. I look forward to working with the talented executive team and fellow board members to help drive the company&#8217;s vision forward and make a meaningful impact in the lives of patients.&#8221;<\/p>\n<p align=\"justify\">Serina also announced the departure of Steven Mintz from its Board of Directors. Mr. Ledger stated, \u201cWe thank Steven for his contributions to Serina\u2019s transition from private to public company and our positioning for future growth.\u201d<\/p>\n<p><strong>About the POZ Platform<\/strong><sup><strong>&#x2122;<\/strong><\/sup><\/p>\n<p align=\"justify\">Serina\u2019s proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Serina\u2019s POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. The therapeutic agents in Serina\u2019s product candidates are typically well-understood and marketed drugs that are effective but may be limited by pharmacokinetic profiles that can include toxicity, side effects and short half-life. Serina believes that by using POZ technology, drugs with narrow therapeutic windows can be designed to maintain more desirable and stable levels in the blood.<\/p>\n<p align=\"justify\">Serina\u2019s POZ platform delivery technology has potential for use across a broad range of payloads and indications. Serina intends to advance additional applications of the POZ platform via out-licensing, co-development, or other partnership arrangements, including the non-exclusive license agreement with Pfizer, Inc. to use Serina\u2019s POZ polymer technology for use in lipid nanoparticle drug (LNP) delivery formulations.<\/p>\n<p align=\"justify\"><strong>About Serina Therapeutics<\/strong><\/p>\n<p align=\"justify\">Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina\u2019s POZ PlatformTM provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HHpaihTbSxDMuXjPO4xdYZm3OUWypjxwZWKLpuQhY_WKJFT1XaTi6XbeKY1Beb23vjz8KcP31MrsnHUBC909xuMXH75xOM06V0aDWdx2s8tavrC23Z67RPwvWPg32paD\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>https:\/\/serinatherapeutics.com<\/u><\/a>.<\/p>\n<p align=\"justify\"><strong>Cautionary Statement Regarding Forward-Looking Statement<\/strong><\/p>\n<p align=\"justify\">This release contains forward-looking statements within the meaning of federal securities laws. These statements are based on management\u2019s current expectations, plans, beliefs or forecasts for the future, and are subject to uncertainty and changes in circumstances. Any express or implied statements in this press release that are not statements of historical fact, including statements about the potential of Serina\u2019s POZ polymer technology, are forward-looking statements that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and\/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and\/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when any applications may be filed for any drug or vaccine candidates in any jurisdictions; whether and when regulatory authorities may approve any potential applications that may be filed for any drug or vaccine candidates in any jurisdictions, which will depend on a myriad of factors, including making a determination as to whether the product\u2019s benefits outweigh its known risks and determination of the product\u2019s efficacy and, if approved, whether any such drug or vaccine candidates will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and\/or other matters that could affect the availability or commercial potential of any drug or vaccine candidates; and competitive developments. These risks as well as other risks are more fully discussed in the company\u2019s Annual Report on Form 10-K for the year ended December 31, 2023, the company\u2019s Current Report on Form 8-K that was filed with the SEC on April 1, 2024, and the company\u2019s other periodic reports and documents filed from time to time with the SEC.<\/p>\n<p align=\"justify\">The information contained in this release is as of the date hereof, and Serina assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.<\/p>\n<p align=\"justify\">For inquiries, please contact:<br \/>Stefan Riley <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ghXYtMjSJYB1fkDo675XanKlGK5hW8Y1pS5Ea0U6luDXL_J-GXN0Z27clrahe9zCO2PEmmeN7Uvt6uW2A5XKMQtj84WQ2Bh7lNpJS3onaRzYZBMz7nr7YlAdg5f-I6io\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>sriley@serinatherapeutics.com<\/u><\/a> <br \/>(256) 327-9630<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzI5M2IwMmMtMjU2NS00MWNmLWE0N2EtZTY4NzkxOTA3M2JmLTUwMDExOTk2NQ==\/tiny\/Serina-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) &#8212; Serina Therapeutics, Inc. (\u201cSerina\u201d) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform&#x2122; drug delivery technology, today announced the appointment of Karen J. Wilson to the Board of Directors. &#8220;We are excited to welcome Karen to the Board of Directors. Karen\u2019s financial expertise and [&#8230;]\n","protected":false},"author":1,"featured_media":63621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-63620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors\" \/>\n<meta property=\"og:description\" content=\"HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) &#8212; Serina Therapeutics, Inc. (\u201cSerina\u201d) (NYSE American: SER), a clinical-stage biotechnology c\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T00:04:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/Serina-Therapeutics-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors\",\"datePublished\":\"2025-01-15T00:04:59+00:00\",\"dateModified\":\"2025-01-15T00:04:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\"},\"wordCount\":942,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\",\"name\":\"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-01-15T00:04:59+00:00\",\"dateModified\":\"2025-01-15T00:04:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors","og_description":"HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) &#8212; Serina Therapeutics, Inc. (\u201cSerina\u201d) (NYSE American: SER), a clinical-stage biotechnology c","og_url":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-01-15T00:04:59+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/Serina-Therapeutics-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors","datePublished":"2025-01-15T00:04:59+00:00","dateModified":"2025-01-15T00:04:59+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/"},"wordCount":942,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/","url":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/","name":"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-01-15T00:04:59+00:00","dateModified":"2025-01-15T00:04:59+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/serina-therapeutics-welcomes-karen-j-wilson-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/63620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=63620"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/63620\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/63621"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=63620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=63620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=63620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}